129 related articles for article (PubMed ID: 18383797)
21. [Complement-binding antibodies in women simultaneously infected with various species of Trichomonas].
Cvetkova A; Ishev V; Andreeva N
Wiad Parazytol; 1988; 34(2):185-90. PubMed ID: 3265240
[No Abstract] [Full Text] [Related]
22. [Cloning, expression and immunogenicity analysis of cysteine proteinase 3 of Trichomonas vaginalis].
Jia WZ; Li Z; Zhao L; Nie FF; Lun ZR
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Dec; 27(6):483-7. PubMed ID: 20232629
[TBL] [Abstract][Full Text] [Related]
23. Isotypes of naturally acquired antibodies to a repetitive & non-repetitive epitope on Plasmodium falciparum surface proteins in an endemic area of Sri Lanka.
Nagendran K; Ramasamy R
Indian J Med Res; 1996 Mar; 103():142-5. PubMed ID: 9062039
[TBL] [Abstract][Full Text] [Related]
24. Complement-mediated regulation of Trichomonas vaginalis infection in mice.
Caterina P; Lynch D; Ashman RB; Warton A; Papadimitriou JM
Exp Clin Immunogenet; 1999; 16(2):107-16. PubMed ID: 10343161
[TBL] [Abstract][Full Text] [Related]
25. Reactive nitrogen intermediates in experimental trichomoniasis induced with isolates from symptomatic and asymptomatic women.
Malla N; Valadkhani Z; Harjai K; Sharma S; Gupta I
Parasitol Res; 2004 Sep; 94(2):101-5. PubMed ID: 15309620
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibodies against Trichomonas vaginalis.
Chang TH; Tsing SY; Tzeng S
Hybridoma; 1986; 5(1):43-51. PubMed ID: 3514432
[TBL] [Abstract][Full Text] [Related]
27. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer.
Sutcliffe S; Giovannucci E; Alderete JF; Chang TH; Gaydos CA; Zenilman JM; De Marzo AM; Willett WC; Platz EA
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):939-45. PubMed ID: 16702374
[TBL] [Abstract][Full Text] [Related]
28. Anti-trichomonad IgA antibodies in trichomoniasis before and after treatment.
Sharma P; Malla N; Gupta I; Ganguly NK; Mahajan RC
Folia Microbiol (Praha); 1991; 36(3):302-4. PubMed ID: 1841864
[TBL] [Abstract][Full Text] [Related]
29. Determination of antiamoebic IgG, IgM, IgA and IgG subclasses in sera from patients with amoebiasis by enzyme-linked immunosorbent assay.
Hock GM; Foon KL; Chuen HL; Choo NG; Singh M
Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):407-14. PubMed ID: 2633348
[TBL] [Abstract][Full Text] [Related]
30. Genetic variability between Trichomonas vaginalis isolates and correlation with clinical presentation.
Rojas L; Fraga J; Sariego I
Infect Genet Evol; 2004 Mar; 4(1):53-8. PubMed ID: 15019590
[TBL] [Abstract][Full Text] [Related]
31. Growth patterns and antigenic analysis of Egyptian Trichomonas vaginalis isolates.
El-Okbi LM; Arafa M; Salama MS; Abou El-Seoud SM; Mohamad AA; Tawfik RA
J Egypt Soc Parasitol; 2004 Dec; 34(3):841-55. PubMed ID: 15587311
[TBL] [Abstract][Full Text] [Related]
32. Trichomonas vaginalis, a pathogen of prostatitis.
van Laarhoven PH
Arch Chir Neerl; 1967; 19(3):263-73. PubMed ID: 4143525
[No Abstract] [Full Text] [Related]
33. Use of a crude extract or a purified antigen of Trichomonas vaginalis for the detection of secretory antibodies by ELISA.
Angeretti A; Merlino C; Savoia D; Martinotti MG
Microbiologica; 1988 Jan; 11(1):29-35. PubMed ID: 3258398
[TBL] [Abstract][Full Text] [Related]
34. Trichomonas vaginalis serostatus and prostate cancer risk in Egypt: a case-control study.
Saleh NE; Alhusseiny SM; El-Zayady WM; Aboelnaga EM; El-Beshbishi WN; Saleh YM; Abou-ElWafa HS; El-Beshbishi SN
Parasitol Res; 2021 Apr; 120(4):1379-1388. PubMed ID: 33159459
[TBL] [Abstract][Full Text] [Related]
35. Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis.
Cogne M; Brasseur P; Ballet JJ
J Clin Microbiol; 1985 Apr; 21(4):588-92. PubMed ID: 3886694
[TBL] [Abstract][Full Text] [Related]
36. In vitro comparative kinetics of adhesive and haemolytic potential of T. vaginalis isolates from symptomatic and asymptomatic females.
Valadkhan Z; Sharma S; Harjai K; Gupta I; Malla N
Indian J Pathol Microbiol; 2003 Oct; 46(4):693-9. PubMed ID: 15025385
[TBL] [Abstract][Full Text] [Related]
37. Detection of antitrichomonal antibodies in sera and cervical secretions in trichomoniasis.
Romia SA; Othman TA
J Egypt Soc Parasitol; 1991 Aug; 21(2):373-81. PubMed ID: 1875069
[TBL] [Abstract][Full Text] [Related]
38. [Indirect immunofluorescence in the serodiagnosis of Trichomonas vaginalis infections].
Sangiorgio M; Barbuto Attiè MC; Granucci E; Ghione M
Boll Ist Sieroter Milan; 1987; 66(1):55-8. PubMed ID: 3304346
[TBL] [Abstract][Full Text] [Related]
39. Serodiagnosis of Trichomonas vaginalis infection by the indirect fluorescent antibody test.
Mason PR
J Clin Pathol; 1979 Dec; 32(12):1211-5. PubMed ID: 395169
[TBL] [Abstract][Full Text] [Related]
40. Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk.
Langston ME; Bhalla A; Alderete JF; Nevin RL; Pakpahan R; Hansen J; Elliott D; De Marzo AM; Gaydos CA; Isaacs WB; Nelson WG; Sokoll LJ; Zenilman JM; Platz EA; Sutcliffe S
Prostate; 2019 Oct; 79(14):1622-1628. PubMed ID: 31376187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
